Similar to last year, the majority of respondents to our online reader survey (conducted in January 2005) named sleep therapy as the fastest growing segment in the respiratory industry. Interestingly, over a quarter of respondents (28%) also said sleep therapy yielded the most reimbursement problems. At the top of the list for reimbursement difficulties was oxygen/oxygen systems (31%). For more of the respiratory puzzle, consider the following additional results.